Evidence map›Paper›PMID 41896574›Full record

ArticleNature communications2026

Molecular evolution and spatial transmission of severe fever with thrombocytopenia syndrome virus.

Yu Leng, Han-Zheng Mu, Ning Cui, Le-Tian Fang, Rong Wang, Xin-Yu Ni, Shuang Li, Hong-Han Ge, Zi-Niu Dai, Rui Wang and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yu Leng *State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Han-Zheng Mu *State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Ning Cui *The 154th Hospital, China RongTong Medical Healthcare Group Co. Ltd., Xinyang, China.
Le-Tian Fang *Department of Epidemiology, Second Military Medical University, Shanghai, China.
Rong Wang *Department of Virus Research, Ningbo Municipal Center for Disease Control and Prevention, Ningbo, Zhejiang, China.
Xin-Yu NiState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Shuang LiState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Hong-Han GeSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.ORCID http://orcid.org/0009-0004-0368-4599
Zi-Niu DaiState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.ORCID http://orcid.org/0000-0003-1449-426X
Rui WangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Xi WangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Xin YangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Bing-Zheng WuState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.
Xiao-Ai ZhangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China.ORCID http://orcid.org/0000-0002-9505-1307
Zhong-Fa WangHealth Monitoring Department, Dinghai Center for Disease Control and Prevention, Zhoushan, Zhejiang, China.
Ling YeDepartment of Infectious Disease Control and Prevention, Daishan Center for Disease Control and Prevention, Zhoushan, Zhejiang, China.
Hao LiState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China. lihao_1986@126.com.ORCID http://orcid.org/0000-0002-6280-267X
Guang-Wen CaoDepartment of Epidemiology, Second Military Medical University, Shanghai, China. gcao@smmu.edu.cn.
Wei LiuState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing, China. lwbime@163.com.ORCID http://orcid.org/0009-0001-6937-2430

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82330103
6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV), an emerging pathogen from the family Phenuiviridae, poses severe threats to public health in East Asia. In this study, we elucidate SFTSV's epidemiological dynamics, transmission patterns, and molecular determinants of virulence, through analysis of 1942 genomes obtained from multiple host species across endemic regions in China, South Korea, Japan, and Thailand (2005-2023). Phylogenetic reconstruction delineates two major lineages (L1-Chinese and L2-Japanese-Korean) comprising 13 genotypes (I-XIII). Viral diversity is shaped by extensive segment-specific reassortment (212 events, including L1-L1, L2-L2, and L1-L2 patterns) and recombination (69 events, 62 in China). The M segment exhibited significantly elevated recombination frequency compared to the L and S segments. Geographically, Hubei province in China emerges as a reassortment hotspot with exceptional genotype diversity, while Henan, Hubei, and Zhejiang provinces serve as key recombination centers. Bayesian phylogeographic analysis traces the origin of SFTSV to the Jiangsu-Anhui border region (~17th century). Subsequent spread occurred through two distinct transmission networks: the L1 lineage disseminated terrestrially from Jiangsu-Anhui/Shandong to the Dabie Mountains and Liaoning province, while the L2 lineage dispersed via marine routes, with South Korea acting as a key transmission hub. Integration of clinical data identifies five positively selected sites and mortality-associated co-mutation networks that are enriched in the genotype IV, which is associated with mortality.

Indexed as

Evolution, MolecularPhlebovirusSevere Fever with Thrombocytopenia SyndromeAnimalsBayes TheoremChinaGenetic VariationGenome, ViralGenotypeHumansPhylogenyPhylogeographyRecombination, Genetic

Identifiers

PMID41896574
PMCPMC13187474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.